Kovina Therapeutics operates as a pre-clinical biotechnology company.
Kovina Therapeutics has raised $275K in total funding. The most recent round was Grant. The last funding was announced in November 2022.
Kovina Therapeutics's investors include BioCrossroads, Elevate Ventures, IU Ventures, National Cancer Institute, National Institute of Allergy and Infectious Diseases.
Kovina Therapeutics is headquartered in Indianapolis, United States.
Kovina Therapeutics operates as a pre-clinical biotechnology company.
Kovina Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kovina Therapeutics — Funding & Investors." VCBacked, November 1, 2022, https://www.vcbacked.co/company/kovina-therapeutics. Accessed September 16, 2026.
VCBacked. (2022). Kovina Therapeutics — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/kovina-therapeutics
{{cite web |title=Kovina Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kovina-therapeutics |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated